Authors


Laura H. Kahn, MD, MPH, MPP

Latest:

One Health: New term, Ancient Concept

How the 9/11 terrorist attacks encouraged the evolution of The One Health Initiative and what that means for the future of medicine.



Francisco A. Durazo, MD, FACP

Latest:

What Should I Do With This Abnormal ALT?

You see a 48-year-old white man for his annual examination. . The patient is overweight with a body mass index (BMI) of 32. A screening chemistry panel is normal except for an aspartate aminotransferase (AST, formerly SGOT) level of 85 U/L (normal 15-50 U/L) and an alanine aminotransferase (ALT, formerly SGPT) level of 98 U/L (normal 5-50 U/L). He says you are the first doctor he has seen in more than 10 years and does not recall the last time he had a blood test.



EDICT Postdoctoral Fellow

Latest:

Clinical Trial Disparities: A Case for Diversity

The challenge of eliminating disparities in clinical trials is being addressed by the Eliminating Disparities in Clinical Trials (EDICT) project, which recognizes that broadening diversity in clinical trials will result in improved effectiveness and safety of future medicines, improved trial quality, and reduced discrepancies in health equity.



Douglas S. Lee, MD, PhD3

Latest:

How do cardiac and noncardiac conditions affect survival after ICD implantation?

The benefits of implantable cardioverter-defibrillators (ICDs) have been shown in randomized clinical trials. The factors that affect the risk–benefit ratio in a community setting, however, have not been evaluated.




Patricia A. Pellikka, MD

Latest:

Stress echocardiography in diabetes mellitus

We assessed how well dobutamine stress echocardiography predicted morbidity and mortality in 2349 patients with diabetes mellitus over a follow-up period of 13.2 years. Results showed that age, failure to achieve the target heart rate, and the percentage of ischemic segments were independent predictors of both mortality and cardiovascular morbidity. Using clinical and stress echocardiographic parameters, a simple model for risk stratification was developed.




The Doctor's Channel

Latest:

Continuous Glucose Monitoring Helps Even Well Controlled Type 1 Diabetics

According to a report in the August 2009 issue of Diabetes Care, even when patients with type 1 diabetes have excellent hemoglobin A1C levels, continuous glucose monitoring will be beneficial.



Gay F. Bailey, RN, MBA, OCN

Latest:

Vocera

Large organizations with mobile workers, such as hospitals, face diminished productivity when communication is inefficient and its employees are unable to locate their coworkers in a timely manner.


MD Magazine

Latest:

Historic Phase 3 Microbiota Trial for C Diff Treatment Completes Enrollment

RBX2660 from Rebiotix will be assessed in a randomized study involving 300 patients.



Tasneem Z. Naqvi, MD1

Latest:

Iatrogenic dilated cardiomyopathy and spectrum of current treatment modalities

Our increasing ability to intervene in high-risk patients—with lower risks and greater chances for successful outcomes—is felt across the broad spectrum of cardiovascular disease. This is particularly evident in patients with dilated cardiomyopathy (DCM).


Kristin Gerson, MD

Latest:

Updated Recommendations for Gestational Diabetes Streamline Screening Methods

In response to the growing prevalence of gestational diabetes mellitus and its associated morbidities, much attention has been paid to the use of appropriate screening methodologies for the metabolic disorder.






Alan H. Kadish, MD

Latest:

Nonischemic cardiomyopathy and implantable cardioverter-defibrillators

We assessed whether duration of nonischemic cardiomyopathy was related to the degree of benefit from implantable cardioverter-defibrillator (ICD) insertion. Subjects who had a recent diagnosis of nonischemic cardiomyopathy had at least a similar benefit from ICD insertion as did those with a remote diagnosis. These results indicate that ICD therapy should be considered in such patients as soon as they are diagnosed and once reversible causes of left ventricular dysfunction have been excluded.




Andrea Roalfe, MSc on behalf of the BAFTA Investigators: From Primary Care Clinical Sciences, University of Birmingham, Birmingham, Unite

Latest:

Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?

We recruited 973 patients (mean age, 81 years) with atrial fibrillation from the primary care setting and randomly assigned them to receive anticoagulation with warfarin or aspirin.


Stephanie Ogozaly

Latest:

Psychological Factors May Explain Treatment Gaps for Patients with Depression

Conflicts between identity and depressive symptoms may account for the significant delays in help-seeking by patients with depression, according to research published October 2, 2012 in BMC Psychiatry.


Kathleen L. Wyne, MD, PhD, is an assistant professor, Division of Endocrinology

Latest:

The time has come for ethnicity-specific CV risk calculators

The risk calculator reported in the Lee et al paper was developed to predict the 10-year cardiovascular (CV) disease probability in an American Indian population.


Jon Stone

Latest:

Opioids Not a Good Idea for Lower Back Pain

Adding opioids or skeletal muscle relaxants to traditional nonsteroidal anti-inflammatory drug (NSAID) treatment for acute lower back pain (LBP) provides little improvement in pain management,

© 2024 MJH Life Sciences

All rights reserved.